The US Food and Drug Administration will ask advisors about evaluating the safety of dietary supplements and food containing cannabinoids more than three years after it opened a window on allowing a regulatory pathway for the ingredients’ lawful use in those products.
A Science Board meeting on 14 June also will come after the FDA opted to keep open indefinitely a docket for comment on hemp and cannabis ingredients’ safety and with...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?